We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based ... read more Featured Products: More products

Download Mobile App




Rapid Methods Compared for Positive Blood Cultures

By LabMedica International staff writers
Posted on 20 May 2014
The need for rapid antibiotic treatment of sepsis is well recognized, and the time to implementation of appropriate antibiotic therapy is critical in improving the outcome of sepsis.

Several methods have been developed to identify pathogens and some antibiotic resistance genes directly from positive blood culture bottles, which can shorten the time for final identification and susceptibility by as much as one to two days.

Medical laboratory scientists at the University of Florida (Gainesville, FL, USA) directly compared a multiplex polymerase chain reaction (PCR) method with a mass spectrometry system to identify organisms in positive blood cultures, between October 2012 and May 2013. More...
They analyzed fluid from 161 positive blood cultures by both methods within 2 to 12 hours of the time the culture signaled positive in BacTec plus aerobic/F bottles incubated in a BacTec 9240 instrument (Becton, Dickinson and Company; Franklin Lakes, NJ, USA).

The two methods used to identify the bacteria were the FilmArray Direct from Positive Blood Culture system (BCID) (BioFire Diagnostics, Salt Lake City, UT, USA) and the VITEK Mass Spectrometry System (Vitek MS, bioMérieux; Durham, NC, USA). The BCID uses multiplex PCR to identify 90% to 95% of common isolates to the genus or species/complex level as well as three antibiotic resistance genes in approximately one hour. The prepared slides for the Vitek MS system were run in a bioMérieux mass spectrometer (Marcy l’Etoile, France).

A total of 132/133 (99%) of isolates that were in the FilmArray panel were identified correctly to the genus and/or species level. For those organisms that the FilmArray could identify to the species or species/complex level, 84/84 (100%) were correctly identified; for those that would only be expected to be identified to the genus level, 48/49 (98%) were identified correctly. The turnaround time for an individual FilmArray test is about an hour and if multiple samples need to be run, multiple instruments may be necessary.

Mass spectrometry correctly identified 142/151 (94%) monomicrobic cultures to the genus level and 137/151 (91%) to the species level. Vitek MS can process up to 48 specimens per slide in approximately an hour, but the actual time to perform a direct identification from a positive blood culture bottle would depend both on the filtration time and the workflow in the clinical microbiology setting to set up the slide and be read in the mass spectrometer.

The authors concluded that both the FilmArray and the VITEK MS mass spectrometry systems were highly accurate and can provide results in about an hour after blood cultures become positive, but the FilmArray is far easier to perform and to incorporate into laboratory workflow. The study was published online on March 22, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

University of Florida
Becton, Dickinson and Company
BioFire Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Blood Protein Analysis Reveals Menopause-Associated Signals of Brain Aging

Menopause affects women across midlife and is often accompanied by endocrine changes, hot flashes, brain fog and sleep disturbances. Women spend roughly one third of their lives after the menopause transition,... Read more

Molecular Diagnostics

view channel
Image: These images show breast tumors in a new preclinical model developed by Garvan researchers. The cells carry a fluorescent sensor that lights up blue/green when CDK1—the protein \'engine\' cells need to divide—is switched on. Using it, the team watched CDK1 activity rise as tumors became invasive and stay high in tumors that kept growing despite treatment. (Image Credit: Dr. Max Nobis / Garvan Institute)

Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer

Estrogen receptor-positive breast cancer is the most common breast cancer subtype and is driven by estrogen. Many patients are treated with CDK4/6 inhibitors alongside hormone therapy, but these drugs... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The ExaccType ESR1 dPCR Kit uses digital PCR technology to detect key ESR1 mutations associated with acquired resistance to endocrine therapy. (Photo courtesy of  BIOTYPE)

Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

Precision medicine in oncology relies on molecular testing to identify biomarkers that can help guide treatment decisions. In hormone receptor-positive, HER2-negative metastatic breast cancer, ESR1 mutations... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.